Approvals/TGA/ADVATE octocog alfa (rch) 250 IU powder for injection vial with diluent vial

Approved

STANDARD

ADVATE octocog alfa (rch) 250 IU powder for injection vial with diluent vial

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1dea2d01032bc83d
Product Name: ADVATE octocog alfa (rch) 250 IU powder for injection vial with diluent vial
Artg Id: 100384
Artg Name: ADVATE octocog alfa (rch) 250 IU powder for injection vial with diluent vial
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2005-04-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01723-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01711-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

1dea2d01032bc83d

Type

Standard